Report error Found 36 with Last Name = 'tanada' and Initial = 'y'
Affinity DataKi: 0.430nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
Affinity DataKi: 9.42nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Binding affinity of the compound towards Vasopressin V1a receptor in rat liverMore data for this Ligand-Target Pair
Affinity DataKi: 1.40E+4nMAssay Description:Binding affinity of the compound towards Vasopressin V1a receptor in human liverMore data for this Ligand-Target Pair
Affinity DataIC50: 0.950nMAssay Description:Concentration of the compound which inhibit [3H]-AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%More data for this Ligand-Target Pair
Affinity DataIC50: 4.10nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 5.90nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 7.5nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 8.80nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 38nMAssay Description:Binding affinity of the compound towards rat Vasopressin V2 receptor after peroral administration of the compoundMore data for this Ligand-Target Pair
Affinity DataIC50: 51nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Binding affinity of the compound towards rat Vasopressin V2 receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 230nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
Affinity DataIC50: 320nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 330nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
Affinity DataIC50: 390nMAssay Description:Binding affinity against Vasopressin V2 receptor was determined in Brattleboro ratsMore data for this Ligand-Target Pair
Affinity DataIC50: 980nMAssay Description:Binding affinity of the compound against human Vasopressin V2 receptor expressed in HeLa cells was determinedMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of [3H]-AVP binding to human Vasopressin V2 receptor expressed in HeLa cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 5.10E+3nMAssay Description:Binding affinity of the compound towards rat Vasopressin V1a receptor after peroral administration of the compoundMore data for this Ligand-Target Pair